Clinical Trials Browser

Withdrawn × Leukemia, Lymphocytic, Chronic, B-Cell × copanlisib × Clear all

NCT04685915 2025-05-22

Copanlisib Plus Ibrutinib or Acalabrutinib in R/R CLL

Phase 2 Withdrawn

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell